Lilly(Eli) & Company
NYSE: LLY
$796.28
+$28.52 (+3.7%)
Closing Price on December 23, 2024
LLY Articles
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins, Eli Lilly, General Electric, Qualcomm...
Published:
Last Updated:
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the...
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo and Roku.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
With the markets at all-time highs, it is prime season for initial public offerings and companies can get more bang for their buck. There were a couple major IPOs this week that lived up to the hype...
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health made a strong entrance to the market on Thursday.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Eli Lilly spin-off Elanco Animal Health has amended its filing with the SEC regarding its initial public offering.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Animal health company Elanco Animal Health has filed with the SEC regarding its initial public offering.
Published:
Last Updated: